These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 33980826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF, Brito JAR, Guimarães ALS, Gomes CC, de Lacerda JCT, de Castro WH, Coimbra RS, Diniz MG, Gomez RS.
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [Abstract] [Full Text] [Related]

  • 6. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
    Murria Estal R, de Unamuno Bustos B, Pérez Simó G, Simarro Farinos J, Torres Navarro I, Alegre de Miquel V, Ballester Sánchez R, Sabater Marco V, Llavador Ros M, Palanca Suela S, Botella Estrada R.
    Melanoma Res; 2021 Feb 01; 31(1):18-26. PubMed ID: 33234848
    [Abstract] [Full Text] [Related]

  • 7. In-depth characterization of microRNA transcriptome in melanoma.
    Kozubek J, Ma Z, Fleming E, Duggan T, Wu R, Shin DG, Dadras SS.
    PLoS One; 2013 Feb 01; 8(9):e72699. PubMed ID: 24023765
    [Abstract] [Full Text] [Related]

  • 8. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V, Zelli V, Gaggiano E, Silvestri V, Rizzolo P, Bucalo A, Calvieri S, Grassi S, Frascione P, Donati P, Soda G, Ottini L, Richetta AG.
    Anticancer Res; 2019 Aug 01; 39(8):4085-4093. PubMed ID: 31366492
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A preliminary study of microRNA expression in different types of primary melanoma.
    Gencia I, Baderca F, Avram S, Gogulescu A, Marcu A, Seclaman E, Marian C, Solovan C.
    Bosn J Basic Med Sci; 2020 May 01; 20(2):197-208. PubMed ID: 31479413
    [Abstract] [Full Text] [Related]

  • 11. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
    Dika E, Riefolo M, Porcellini E, Broseghini E, Ribero S, Senetta R, Osella-Abate S, Scarfì F, Lambertini M, Veronesi G, Patrizi A, Fanti PA, Ferracin M.
    J Invest Dermatol; 2020 Nov 01; 140(11):2260-2267. PubMed ID: 32275975
    [Abstract] [Full Text] [Related]

  • 12. Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
    Antonova E, Hambikova A, Shcherbakov D, Sukhov V, Vysochanskaya S, Fadeeva I, Gorshenin D, Sidorova E, Kashutina M, Zhdanova A, Mitrokhin O, Avvakumova N, Zhernov Y.
    Int J Mol Sci; 2023 May 23; 24(11):. PubMed ID: 37298110
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.
    Babapoor S, Wu R, Kozubek J, Auidi D, Grant-Kels JM, Dadras SS.
    Lab Invest; 2017 Jun 23; 97(6):636-648. PubMed ID: 28218741
    [Abstract] [Full Text] [Related]

  • 15. Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
    DiVincenzo MJ, Angell CD, Suarez-Kelly LP, Ren C, Barricklow Z, Moufawad M, Fadda P, Yu L, Backes FJ, Ring K, Mills A, Slingluff C, Chung C, Gru AA, Carson WE.
    PLoS One; 2023 Jun 23; 18(6):e0285804. PubMed ID: 37384650
    [Abstract] [Full Text] [Related]

  • 16. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV, Martin EC, Segar HC, Miller DF, Buechlein A, Rusch DB, Nephew KP, Burow ME, Collins-Burow BM.
    Oncotarget; 2015 Jun 30; 6(18):16638-52. PubMed ID: 26062653
    [Abstract] [Full Text] [Related]

  • 17. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
    Prodan M, Costescu S, Elagez A, Laitin SMD, Bloanca V, Crainiceanu Z, Seclaman E, Toma AO, Fericean RM, Puenea G, Cozma GV.
    Curr Oncol; 2024 May 17; 31(5):2881-2894. PubMed ID: 38785501
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
    Elango R, Alsaleh KA, Vishnubalaji R, Manikandan M, Ali AM, Abd El-Aziz N, Altheyab A, Al-Rikabi A, Alfayez M, Aldahmash A, Alajez NM.
    Front Oncol; 2020 May 17; 10():756. PubMed ID: 32509578
    [Abstract] [Full Text] [Related]

  • 19. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
    DiVincenzo MJ, Schwarz E, Ren C, Barricklow Z, Moufawad M, Yu L, Fadda P, Angell C, Sun S, Howard JH, Chung C, Slingluff C, Gru AA, Kendra K, Carson WE.
    J Invest Dermatol; 2023 Apr 17; 143(4):630-638.e3. PubMed ID: 36202232
    [Abstract] [Full Text] [Related]

  • 20. Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma.
    Polini B, Carpi S, Doccini S, Citi V, Martelli A, Feola S, Santorelli FM, Cerullo V, Romanini A, Nieri P.
    Int J Mol Sci; 2020 Aug 27; 21(17):. PubMed ID: 32867069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.